HC Wainwright & Co. Maintains Buy on Bicycle Therapeutics, Lowers Price Target to $55
HC Wainwright & Co. Maintains Buy on Bicycle Therapeutics, Lowers Price Target to $55
HC Wainwright & Co.維持對自行車療法的買入，將目標股價下調至55美元
HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Bicycle Therapeutics (NASDAQ:BCYC) with a Buy and lowers the price target from $57 to $55.
HC Wainwright & Co. 分析師Swayampakula Ramakanth維持Bicycle Therapeutics（納斯達克股票代碼：BCYC）的買入並將目標股價從57美元下調至55美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。